Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma. - Zhao, Junjie; Tang, Yanfeng; Hu, Xu; Yin, Xiaoxue; Chen, Yuntian; Chen, Junru; Liu, Haoyang; Liu, Haolin; Liang, Jiayu; Zhang, Xingming; Zhao, Jinge; Zhu, Sha; et al. (Molecular Cancer, 2024)